Download FREE Report Sample
Download Free sampleClindamycin is a lincomylamine antibiotic commonly used to treat infections of anaerobic bacteria but also protozoan diseases such as malaria.It is a common topical prescription for acne and is effective in treating drug-resistant staphylococcus aureus (MRSA) infections.
Clindamycin Market contains market size and forecasts of Clindamycin in Global, including the following market information:
Global Clindamycin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Clindamycin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Clindamycin include Glenmark Pharmaceuticals, Prasco Laboratories, Valent Pharmaceuticals, Dow PharmaceuticalsSciences, Bausch Health, Dermik Laboratories, Angita Pharma, Apotex Corporation and Auro Pharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Clindamycin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Clindamycin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Clindamycin Market Segment Percentages, by Type, 2021 (%)
Oral
Injection
Preparation
Global Clindamycin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Clindamycin Market Segment Percentages, by Application, 2021 (%)
Infectious Diseases Caused By Positive Bacteria
Infectious Diseases Caused By Anaerobe
Global Clindamycin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Clindamycin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Clindamycin revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Clindamycin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Glenmark Pharmaceuticals
Prasco Laboratories
Valent Pharmaceuticals
Dow PharmaceuticalsSciences
Bausch Health
Dermik Laboratories
Angita Pharma
Apotex Corporation
Auro Pharma
Avanstra Inc
Physicians Total Care
Pharmacia and Upjohn Company
Zhuhai Lianbang Pharmaceutical
Zhongshan Branch Yunnan Plant Pharmaceutical
Shandong Fangming Pharmaceutical Group
Suzhou No. 4 Pharmaceutical Factory
Golden Sun Pharmaceutical Chongqing Kerui Pharmaceutical Group
Chongqing Kerui Pharmaceutical Group
Heilongjiang Tianchen Pharmaceutical
Jiangsu Zhongdan Pharmaceutical
Hebei Huanuo
Shenzhen Dafu Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
